Arthrex Licenses Rights to Autopose for Orthopedics and Sports Medicine

By Julie A. Vetalice

Arthrex Licenses Rights to Autopose for Orthopedics and Sports Medicine

Arthrex entered into an exclusive partnership to globally market Bimini Health Tech's Autopose family of products for the harvesting and micro-fragmentation of adipose tissue. Bimini will provide Arthrex with exclusive commercial distribution rights for the orthopedic surgery and sports medicine fields of use and will continue to be responsible for product manufacturing and supply.

The Autopose portfolio of products allows for sterile closed-loop processing of lipoaspirate tissue in procedures involving the recovery, concentration and transfer of autologous adipose tissue for use in orthopedic and arthroscopic procedures.

Bradford Conlan, Chief Executive Officer of Bimini Health Tech, said, "The Autopose platform allows for the safe harvesting and processing of autologous adipose tissue, for those that are not accustomed, and leverages the unique properties of the patient's own adipose tissue. We look forward to working closely with Arthrex to increase the availability of these innovative products in orthopedic surgery and sports medicine, and to improve the lives of patients."

Arthrex Group Product Manager Rob Harrison added, "Arthrex is excited to partner with Bimini Health Tech and its' innovative technology that redefines the standard of adipose tissue recovery. Partnering with Bimini Health Tech positions us to explore other opportunities in the Orthobiologics space while continuing our mission of helping surgeons better treat their patients."

Source: Bimini Health Tech

Product Labels: PRP/Cell-Based/Osteoinductive Materials